[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","course_id":"PHMSCI 770","course_uid":"course_3fccebda183122da4a95adb6","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","course_number":770,"subjects":["PHMSCI"],"title":"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS I","description":"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes. Develops skills in primary literature analysis to enable conceptual integration of information across chemical, molecular, cellular, systems, and societal levels. Not open to students with credit for PHARMACY 770 prior to fall 2026.","requirements_text":"Declared in MS Pharmaceutical Sciences"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","course_id":"PHMSCI 770","course_uid":"course_3fccebda183122da4a95adb6","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","course_number":770,"subjects":["PHMSCI"],"title":"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS I","description":"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes. Develops skills in primary literature analysis to enable conceptual integration of information across chemical, molecular, cellular, systems, and societal levels. Not open to students with credit for PHARMACY 770 prior to fall 2026.","requirements_text":"Declared in MS Pharmaceutical Sciences"}]